Prana Biotechnology (PRAN) annual income statement covering fiscal 2016 through 2018, as reported to the SEC. This statement has 1 line item across 3 periods.
An income statement shows what a company sold and what it cost to run the business, ending with the profit left over.
| Jun'18 | Jun'17 | Jun'16 | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Weighted average number of ordinary shares used in computing basic and diluted net loss per share (In shares) | ||||||||||||||||||
533,891 | 533,891 | 533,891 | xxxxx | xxxxx | xxxxx | xxxxx | xxxxx | xxxxx | xxxxx | xxxxx | xxxxx | xxxxx | ||||||
Weighted average number of ordinary shares used in computing basic and diluted net loss per share (In shares) | 533,891 | 533,891 | 533,891 | xxxxx | xxxxx | xxxxx | xxxxx | xxxxx | xxxxx | xxxxx | xxxxx | xxxxx | xxxxx | |||||